BMC Infectious Diseases | |
Cost-effectiveness analysis of N95 respirators and medical masks to protect healthcare workers in China from respiratory infections | |
Research Article | |
Anthony T. Newall1  Shohini Mukerji1  Holly Seale1  C. RainaMacIntyre2  Peng Yang3  Xiaoli Wang3  Quanyi Wang3  | |
[1] School of Public Health and Community Medicine, The University of New South Wales, 2052, Sydney, NSW, Australia;School of Public Health and Community Medicine, The University of New South Wales, 2052, Sydney, NSW, Australia;National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), University of Sydney, Westmead, NSW, Australia;The Beijing Centre for Disease Control and Prevention, Beijing, China; | |
关键词: Cost-effectiveness; Economic evaluation; N95 respirator; Mask; Healthcare worker; | |
DOI : 10.1186/s12879-017-2564-9 | |
received in 2016-09-10, accepted in 2017-06-23, 发布年份 2017 | |
来源: Springer | |
【 摘 要 】
BackgroundThere are substantial differences between the costs of medical masks and N95 respirators. Cost-effectiveness analysis is required to assist decision-makers evaluating alternative healthcare worker (HCW) mask/respirator strategies. This study aims to compare the cost-effectiveness of N95 respirators and medical masks for protecting HCWs in Beijing, China.MethodsWe developed a cost-effectiveness analysis model utilising efficacy and resource use data from two cluster randomised clinical trials assessing various mask/respirator strategies conducted in HCWs in Level 2 and 3 Beijing hospitals for the 2008–09 and 2009–10 influenza seasons. The main outcome measure was the incremental cost-effectiveness ratio (ICER) per clinical respiratory illness (CRI) case prevented. We used a societal perspective which included intervention costs, the healthcare costs of CRI in HCWs and absenteeism costs.ResultsThe incremental cost to prevent a CRI case with continuous use of N95 respirators when compared to medical masks ranged from US $490–$1230 (approx. 3000-7600 RMB). One-way sensitivity analysis indicated that the CRI attack rate and intervention effectiveness had the greatest impact on cost-effectiveness.ConclusionsThe determination of cost-effectiveness for mask/respirator strategies will depend on the willingness to pay to prevent a CRI case in a HCW, which will vary between countries. In the case of a highly pathogenic pandemic, respirator use in HCWs would likely be a cost-effective intervention.
【 授权许可】
CC BY
© The Author(s). 2017
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202311097834571ZK.pdf | 715KB | download |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]